Federal contract award
75F40124P00405
HUMAN DONOR BLOOD FOR BIOASSAY DEVELOPMENT
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 621991 — Blood and Organ Banks |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $47.4K |
| Current contract value | $47.4K |
| Potential contract value / ceiling | $47.4K |
| Start date | Sep 6, 2024 |
| Current end date | Aug 31, 2025 |
| Potential end date | Jul 28, 2026 |
| Latest award activity | Jul 29, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 29, 2026 | P00001 | $-30 | THE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE EXCESS FUNDS AND CLOSE OUT THE CONTRACT. |
| Sep 6, 2024 | 0 | $47.5K | HUMAN DONOR BLOOD FOR BIOASSAY DEVELOPMENT |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| PATRICIA NATIVIDAD | Contact | PATRICIA.NATIVIDAD@FDA.HHS.GOV 3017968919 | Source | Aug 4, 2024 |
Research next steps
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.